Search Results 251-260 of 17105 for prolia

  1. Pulmonary Medicine Clinical Trials - Medical Professionals

    Find pulmonary clinical trials at your nearest Mayo Clinic location.

  2. Polycythemia vera - Doctors and departments - Mayo Clinic

    This slow-growing blood cancer mainly affects people over 60. Treatments and lifestyle changes may reduce complications and ease symptoms.

  3. Prostate MRI - Mayo Clinic

    Overview. Prostate magnetic resonance imaging (MRI) is a test that creates detailed pictures of the prostate. MRI uses a magnetic field and radio waves to ...

  4. Pediatrics Clinical Trials - Medical Professionals

    The purpose of this study is to determine if open surgical resection is superior to thoracoscopic resection for thoracic event-free survival (tEFS) in ...

  5. A Study of LY2784544 for Patients with Myeloproliferative Disorders - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. A study to create and analyze a comprehensive longitudinal resource using testing results from those with genetic risk of Alzheimer's disease - Mayo Clinic

    About this study. This study aims to establish, use, and extensively share a comprehensive longitudinal resource of genetic, non-genetic, and cognitive data ...

  7. Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) - Mayo Clinic

    The purpose of this multi-center event-driven study in participants with anemia associated with chronic kidney disease (CKD) to evaluate the safety and efficacy ...

  8. A Study to Evaluate the Effectiveness and Tolerability of a Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis - Mayo Clinic

    Inclusion Criteria: Biopsy proven cutaneous mastocytosis with or without evidence of systemic disease. Male and female patients, 18 to 80 years of age.

  9. Safety Study of VAL-083 in Patients with Recurrent Malignant Glioma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

    Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has ...